Bioniche Life Sciences Inc.
Registration:
2
of
30
(2006-03-16
to
2006-09-21)
Subject Matter: Retrospective:
|
Ongoing discussions relating to Technology Partnerships Canada funding.
|
Subject Matter: Prospective:
|
Ongoing compliance with obligations of the Technology Partnerships Canada funding program.Potential discussions with various government departments relating to vaccine production.Ongoing discussions with Revenue Canada relating to taxation issues.
|
Details Regarding the Identified Subject Matter
Categories
|
Description
|
Grant, Contribution or Other Financial Benefit
|
Technology Partnerships Canada Program
|
Policy or Program
|
Technology Partnerships Canada Program relating to the development and commercialization of an E. coli vaccine and to Mycobacterial Cell Wall Technologies.
|